Bladder cancer Board decisions

The Veteran's ischemic heart disease is granted as related to his service, including exposure to Agent Orange.,Bladder cancer was dismissed due to the grant of service connection for bladder cancer in a separate decision.,Diabetes mellitus type 2 is granted on both presumptive and direct bases due to exposure to Agent Orange.,Left lower extremity peripheral neuropathy is granted as secondary to diabetes mellitus.,Right lower extremity peripheral neuropathy is granted as secondary to diabetes mellitus.,Right upper extremity peripheral neuropathy is remanded for further review.,Left upper extremity peripheral neuropathy is remanded for further review.

The Veteran's claims for increased evaluation of tinnitus and service connection for vasculitis, bladder cancer, colon cancer, and prostate cancer have been remanded due to the need for additional medical opinions.

The Veteran's appeal for service connection for bladder cancer was dismissed because the Notice of Disagreement (NOD) was not filed within one year from the date of the July 2018 rating decision.

The Veteran's bladder cancer has been granted a 100 percent evaluation since April 2, 2019. The rating was previously at zero percent from September 1, 2019.

The Board has granted service connection for bladder cancer on a presumptive basis due to exposure to Agent Orange during the Veteran's service at U-Tapao Air Force Base in Thailand. The decision also grants service connection on a direct basis based on the Veteran's exposure to Agent Orange and his duties as a munition's specialist.

The Veteran's claim for service connection for bladder cancer is denied because he did not serve in the Republic of Vietnam, and therefore, he is not a Nehmer class member.

The Board has granted service connection for urostomy s/p cystectomy for bladder cancer and kidney transplant as secondary to the bladder cancer, both due to in-service exposure to asbestos.

The Veteran's seizure disability was granted effective August 9, 2022.,An increased rating of 60 percent for bladder cancer residuals was granted effective May 1, 2018. The Veteran is also now eligible for TDIU from that date.

The Veteran's bladder cancer, diabetes mellitus type II and heart disease are granted service connection as they are presumed to be due to herbicide exposure during his military service.

The Veteran's claim for an initial compensable disability rating for residuals of bladder cancer is being remanded due to the failure to comply with prior remand instructions.

The Veteran's claim for service connection for diabetes mellitus type II has been granted, with the evidence showing that his in-service exposure to toxins caused his condition.,The Veteran's claim for service connection for bladder cancer has also been granted, with the evidence showing that his in-service exposure to toxins caused his condition.

The Veteran's claims for an effective date prior to January 17, 2019, for service connection for bladder cancer and special monthly compensation based on housebound criteria were denied. The claim for a rating in excess of 20 percent for residuals of bladder cancer was also denied.

The Board denied service connection for a bilateral eye condition and an initial rating in excess of 70 percent for PTSD, while remanding multiple other claims related to various disabilities.

The Veteran's skin disability is related to service and granted. The claims for depression, anxiety, bilateral hearing loss, tinnitus, diabetes mellitus, hemorrhoids, diverticular disability, erectile dysfunction, prostate cancer, bladder cancer, gall bladder disability, and hernia are denied.

The Veteran's claims for kidney disorder and prostate disorder, including as secondary to bladder cancer, are remanded due to a duty-to-assist error. The Veteran has been diagnosed with benign prostatic hypertrophy but not prostate cancer.

The Veteran's claims for service connection for bladder cancer and a kidney condition also claimed as renal toxicity secondary to bladder cancer are being readjudicated due to the submission of new evidence. The AOJ must consider this new evidence in its decision.

The Board granted service connection for multiple heart disabilities, diabetes mellitus, type II, hypothyroidism, bladder cancer, hypertension, diabetic nephropathy, peripheral neuropathies, bilateral non-proliferative diabetic retinopathy, and erectile dysfunction based on the Veteran's exposure to herbicides in Korea.

The Board denied the claim for an earlier effective date for service connection for bladder cancer due to lack of evidence showing a prior denial between September 25, 1985 and May 3, 1989. The Veteran's claim was received within one year after his separation from active duty, thus November 25, 2019 is the correct effective date for service connection.

The Veteran's claim for an earlier effective date prior to December 18, 2017, for service connection of bladder cancer was denied.,The Veteran's claim for a 100 percent disability rating for bladder cancer from February 1, 2019, to May 28, 2019, was granted.

The Veteran's skin disability is related to service and granted. The claims for depression, anxiety, bilateral hearing loss, tinnitus, diabetes mellitus, hemorrhoids, diverticular disability, erectile dysfunction, prostate cancer, bladder cancer, gall bladder disability, and hernia are denied.